We are studying genetic risk factors and long-term complications of Stevens-Johnson syndrome and toxic epidermal necrolysis  (SJS/TEN). We would appreciate you sharing this flyer with appropriate patients before they leave your Burn Unit or when you see them in clinic for follow-up. Our study and this advertisement have been IRB approved through the Vanderbilt University Medical Center IRB# 191350.  We have IRB approval for SJS survivors to contact us through the REDCap link  on the flier – please access flier.

Please contact the study team with any questions:

Elizabeth J. Phillips, MD, FIDSA, FAAAAI Professor, Department of Medicine, Division of Infectious Disease John Oates Chair, Clinical Research, Oates Institute for Experimental Therapeutics Professor, Pathology, Microbiology and Immunology Professor, Department of Pharmacology (615) 310-0339 or elizabeth.j.phillips@vumc.org

Study Coordinators:  Elizabeth Harter (Elizabeth.harter@vumc.org) and our general research address:  drugsafetyresearch@vumc.org

For information on COVID-19 vaccination and SJS/TEN please see here.